A New Frontier of Biomarker Testing

SUMMARY

Join Professor Andrew Tutt as he discusses the clinical application of methylation-based testing in metastatic breast cancer. Hear about data published in the Annals of Oncology showing how Guardant Infinity technology is shaping the future of precision medicine.